Recent studies have investigated the association between tau pathology and downstream neurodegeneration in healthy, cognitively normal, prodromal AD, and AD dementia [5, 7–9, 36–38] individuals, as well as in clinical subtypes of AD [39–41]. The gene discussed is MAPT; the disease is Alzheimer disease.